Vaxart (NASDAQ:VXRT) Given New $2.00 Price Target at B. Riley
Vaxart (NASDAQ:VXRT – Get Free Report) had its price target decreased by stock analysts at B. Riley from $2.50 to $2.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. B. Riley’s price objective points to a potential upside of 374.83% from the stock’s […]
Vaxart (NASDAQ:VXRT – Get Free Report) had its price target decreased by stock analysts at B. Riley from $2.50 to $2.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. B. Riley’s price objective points to a potential upside of 374.83% from the stock’s […]
